Researcher profile

Richard M. Myers

Richard M. Myers contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 15 - UnverifiedVerification L1Unclaimed author
3works
0followers
5topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2022arXiv

Concept validation of a high dynamic range point-diffraction interferometer for wavefront sensing in adaptive optics

The direct detection and imaging of exoplanets requires the use of high-contrast adaptive optics (AO). In these systems quasi-static aberrations need to be highly corrected and calibrated. In order to achieve this, the pupil-modulated point-diffraction interferometer (m-PDI), was presented in an earlier paper. This present paper focuses on m-PDI concept validation through three experiments. First, the instrument's accuracy and dynamic range are characterised by measuring the spatial transfer function at all spatial frequencies and at different amplitudes. Then, using visible monochromatic light, an adaptive optics control loop is closed on the system's systematic bias to test for precision and completeness. In a central section of the pupil with 72% of the total radius the residual error is 7.7nm-rms. Finally, the control loop is run using polychromatic light with a spectral FWHM of 77nm around the R-band. The control loop shows no drop in performance with respect to the monochromatic case, reaching a final Strehl ratio larger than 0.7.

preprint2022arXiv

Field Theory of Interacting Boundary Gravitons

Pure three-dimensional gravity is a renormalizable theory with two free parameters labelled by $G$ and $Λ$. As a consequence, correlation functions of the boundary stress tensor in AdS$_3$ are uniquely fixed in terms of one dimensionless parameter, which is the central charge of the Virasoro algebra. The same argument implies that AdS$_3$ gravity at a finite radial cutoff is a renormalizable theory, but now with one additional parameter corresponding to the cutoff location. This theory is conjecturally dual to a $T\overline{T}$-deformed CFT, assuming that such theories actually exist. To elucidate this, we study the quantum theory of boundary gravitons living on a cutoff planar boundary and the associated correlation functions of the boundary stress tensor. We compute stress tensor correlation functions to two-loop order ($G$ being the loop counting parameter), extending existing tree level results. This is made feasible by the fact that the boundary graviton action simplifies greatly upon making a judicious field redefinition, turning into the Nambu-Goto action. After imposing Lorentz invariance, the correlators at this order are found to be unambiguous up to a single undetermined renormalization parameter.

preprint2020arXiv

Blocking of the CD80/86 axis as a therapeutic approach to prevent progression to more severe forms of COVID-19

In its more severe forms, COVID-19 progresses towards an excessive immune response, leading to the systemic overexpression of proinflammatory cytokines like IL6, mostly from the infected lungs. This cytokine storm can cause multiple organ damage and death. Consequently, there is a pressing need to identify therapies to treat and prevent severe symptoms during COVID-19. Based on previous clinical evidence, we hypothesized that inhibiting T cell co-stimulation by blocking CD80/86 could be an effective therapeutic strategy against progression to severe proinflammatory states. To support this hypothesis, we performed an analysis integrating blood transcriptional data we generated from rheumatoid arthritis patients treated with abatacept -- a CD80/86 co-stimulation inhibitor -- with the pathological features associated with COVID-19, particularly in its more severe forms. We have found that many of the biological processes that have been consistently associated with COVID-19 pathology are reversed by CD80/86 co-stimulation inhibition, including the downregulation of IL6 production. Also, analysis of previous transcriptional data from blood of SARS-CoV-infected patients showed that the response to abatacept has a very high level of antagonism to that elicited by COVID-19. Finally, analyzing a recent single cell RNA-seq dataset from bronchoalveolar lavage fluid cells from COVID-19 patients, we found a significant correlation along the main elements of the C80/86 axis: CD86+/80+ antigen presenting cells, activated CD4+ T cells and IL6 production. Our in-silico study provides additional support to the hypothesis that blocking of the CD80/CD86 signaling axis may be protective of the excessive proinflammatory state associated with COVID-19 in the lungs.